Addex Therapeutics Files Form 6-K with SEC
Ticker: ADXN · Form: 6-K · Filed: Jun 25, 2025 · CIK: 1574232
Sentiment: neutral
Topics: sec-filing, press-release, disclosure
TL;DR
Addex Therapeutics dropped a 6-K filing on 6/25/25, likely with news.
AI Summary
On June 25, 2025, Addex Therapeutics Ltd. announced the issuance of a press release, incorporated by reference as Exhibit 99.1 to this Form 6-K filing. This press release is expected to contain information relevant to the company's ongoing operations and disclosures.
Why It Matters
This filing indicates that Addex Therapeutics is providing updated information to the SEC, which could include material developments relevant to investors.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain immediate negative or positive material news.
Key Players & Entities
- Addex Therapeutics Ltd. (company) — Registrant
- June 25, 2025 (date) — Date of press release and filing
- Exhibit 99.1 (document) — Incorporated press release
- Form F-3 (Registration No. 333-255089) (document) — Registration statement
- Form S-8 (Registration No. 333-255124) (document) — Registration statement
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report a press release issued by Addex Therapeutics Ltd. on June 25, 2025, which is incorporated by reference as Exhibit 99.1.
What is the filing date of this Form 6-K?
The filing date is June 25, 2025.
What are the registration numbers mentioned in the filing?
The filing mentions registration numbers 333-255089 for Form F-3 and 333-255124 for Form S-8.
Where is Addex Therapeutics Ltd. located?
Addex Therapeutics Ltd. is located at Chemin des Mines 9, CH-1202 Geneva, Switzerland.
What type of report is this Form 6-K considered?
This Form 6-K is considered a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 25, 2025 regarding Addex Therapeutics Ltd. (ADXN).